Roger M. Perlmutter's Insider Trades & SAST Disclosures

Roger M. Perlmutter's most recent trade in Ngm Biopharmaceuticals Inc was a trade of 78,407 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 5, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ngm Biopharmaceuticals Inc
Roger M. Perlmutter Director Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2024 78,407 0 - - Stock Option (Right to Buy)
Ngm Biopharmaceuticals Inc
Roger M. Perlmutter Director Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2024 46,238 0 - - Stock Option (Right to Buy)
Ngm Biopharmaceuticals Inc
Roger M. Perlmutter Director Sale or transfer of securities back to the company at price $ 0.00 per share. 05 Apr 2024 24,222 0 - - Stock Option (Right to Buy)
Ngm Biopharmaceuticals Inc
Roger M. Perlmutter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2022 24,222 24,222 - - Stock Option (Right to Buy)
Ngm Biopharmaceuticals Inc
Roger M. Perlmutter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 46,238 46,238 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades